1. Home
  2. TXMD vs EVAX Comparison

TXMD vs EVAX Comparison

Compare TXMD & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.23

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$3.14

Market Cap

27.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXMD
EVAX
Founded
2008
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.9M
27.4M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
TXMD
EVAX
Price
$2.23
$3.14
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$12.33
AVG Volume (30 Days)
33.0K
32.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
80.61
N/A
EPS
N/A
N/A
Revenue
$1,761,000.00
N/A
Revenue This Year
$427.09
$129.07
Revenue Next Year
N/A
N/A
P/E Ratio
$90.64
N/A
Revenue Growth
35.25
N/A
52 Week Low
$0.72
$1.20
52 Week High
$2.95
$12.15

Technical Indicators

Market Signals
Indicator
TXMD
EVAX
Relative Strength Index (RSI) 49.23 39.29
Support Level $1.05 $2.56
Resistance Level $2.54 $3.54
Average True Range (ATR) 0.13 0.22
MACD -0.02 0.04
Stochastic Oscillator 40.91 25.62

Price Performance

Historical Comparison
TXMD
EVAX

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: